Skip to main content
Full access
Letters
Published Online: 1 April 2011

Voltage-Gated, Potassium-Channel Antibody-Associated Limbic Encephalitis Presenting as Acute Psychosis

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: Voltage-gated, potassium-channel (VGKC) antibody-associated limbic encephalitis is a neurological condition characteristically associated with confusion, memory disturbance, epilepsy, and altered behavior. Early diagnosis is crucial because, unlike other neurodegenerative conditions, it is potentially fully reversible with immunotherapy. 1 We describe the first such case, to our knowledge: a 58-year-old man who presented with a florid psychiatric outburst including severe self-harm, with multiple self-inflicted stab wounds, subsequently diagnosed with VGKC antibody-associated limbic encephalitis.

Case Presentation

A 58-year-old man was admitted to the hospital in April 2008 with increasing frequency of seizures, confusion, slurred speech, ataxia, and falls. He had a previous history of excess alcohol consumption, depression, and deliberate self-harm. The patient's depressive symptoms began in August 2006 and were associated with episodes of amnesia and confusion. A year later (August 2007) the patient was admitted with an episode of severe self-harm. This was particularly disturbing, as the patient had self-inflicted multiple stab wounds with a knife to his neck, chest, abdomen, and upper limbs. Computed tomography (CT) scan of the chest and abdomen revealed a left pneumothorax, left pleural effusion, and free gas in the peritoneal cavity. Urgent laparotomy showed multiple anterior abdominal wall lacerations but no intra-abdominal organ injury. A chest drain was inserted to drain the left hemo-pneumothorax. Upper limb injuries included multiple right flexor tendon injuries and a deep laceration to the left biceps tendon, all of which required surgical repair. A psychiatric assessment at this stage concluded that the patient was suffering with paranoid delusions and auditory and visual hallucinations; he was subsequently diagnosed with paranoid schizophrenia. He was started on olanzapine, which resulted in some improvement of his psychotic symptoms. Over the next 2 months, his cognitive functioning deteriorated significantly, with progressive amnesia, personality change in the form of aggression, and new-onset epilepsy. Comparison of his previous Mini-Mental State Exam scores showed a rapid decline, from 26/30 to 8/30 in 2 months. His epilepsy worsened, and the seizures became both bizarre and resistant to multiple anticonvulsants. On this admission, blood investigations were all normal, apart from low serum sodium. The hyponatremia (ranging from 122 mmol/liter to 126 mmol/liter) in retrospect had persisted over 10 months (Figure 1). Plasma and urine osmolality suggested this to be due to the syndrome of inappropriate ADH secretion (SIADH). A brain MRI showed nonspecific areas of high signal. CSF analysis and an EEG were normal. Investigations for neurological infections, malignancy (CT scans of the chest, abdomen, and pelvis, and tumor markers), onco-neuronal, autoimmune, and thyroid antibodies were all negative, but serum voltage-gated, potassium-channel antibodies (VGKC-Abs) were elevated, at 506 pmol/liter (normal range: 0–100 pmol/liter). A diagnosis of limbic encephalitis (LE) was made on the basis of these findings. The patient was treated with plasma exchange, followed by intravenous immunoglobulins and corticosteroids. A repeat VGKC antibody titer 3 months later showed a reduction to 253 pmol/liter, which coincided with improvement in serum sodium levels, as well as improvement in the patient's seizure frequency and aggressive behavior. There was minor improvement in his cognitive functioning, although it is likely that the patient had suffered with autoimmune (VGKC antibody-associated) LE for nearly 2 years, which may have caused permanent neuronal damage irreversible by immunotherapy.
FIGURE 1. Time-Line of Symptom Development in Limbic Encephalitis

Discussion

Neuropsychiatric symptoms form a key part of VGKC antibody-associated LE and are often the presenting feature of this condition.15 Autoimmune-mediated damage to limbic structures result in amnesia, cognitive decline, and epilepsy. Acute psychosis of this severity has not been previously reported, and it highlights the diversity of this condition's clinical spectrum. It is difficult to determine precisely when our patient developed this condition, but we assume it was at least 12 months before the episode of acute psychosis. The initial episodes (August 2006) of confusion, memory loss, and depressive symptoms could well have been the first manifestations of the illness. The patient's psychotic episode, which resulted in extreme self-mutilation (August 2007) was deemed to be primarily due to a psychiatric cause. The possibility of an organic cause was not considered—ultimately delaying the diagnosis. It was only several months later that he began to deteriorate more rapidly, with symptomatic memory loss, cognitive decline, and seizures that led to the diagnosis of LE nearly 2 years after his initial symptoms. Epilepsy and hyponatremia appear to be important features of this condition's clinical syndrome. Seizures appear to develop later in the disease and are often both diverse and difficult to treat.15 Hyponatremia is well described in several case series and reports of LE; the cause is thought to be SIADH, as was the case in our patient. In nearly all cases, the hyponatremia is resistant to standard treatment such as fluid restriction, but corrects after treatment with immunoglobulins and/or plasma exchange.1,4,5 In this case, the onset of hyponatremia coincided with the onset of his clinical deterioration, suggesting a temporal relationship and a potential marker for disease activity. (The association between serum sodium measurements and clinical symptoms over a 3-year period is shown in Figure 1). VGKC antibody-associated encephalitis is a subacute, degenerative neurological condition potentially reversible with immunotherapy. Neuropsychiatric symptoms in the presence of persistent hyponatremia and seizures are key presenting features that should alert the clinician to the possibility of autoimmune LE. Acute psychosis is a rare and unusual presentation, but if associated with other clinical features suggestive of LE, testing for VGKC antibodies should be performed.

References

1.
Vincent A, Buckley C, Schott JM, et al.: Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004; 127:701–712
2.
Rueff L, Graber JJ, Bernbaum M, et al.: Voltage-gated potassium channel antibody-mediated syndromes: a spectrum of clinical manifestations. Rev Neurol Dis 2008; 5:65–72
3.
Hiraga A, Kuwabara S, Hayakawa S, et al.: Voltage-gated potassium channel antibody-associated encephalitis with basal ganglia lesions. Neurology 2006; 66:1780–1781
4.
Harrower T, Foltynie T, Kartsounis L, et al.: A case of voltage-gated potassium channel antibody-related limbic encephalitis. Nat Clin Pract Neurol 2006; 2:339–343
5.
Parthasarathi U, Harrower T, Tempest M, et al.: Psychiatric presentation of voltage-gated potassium channel antibody-associated encephalopathy. Br J Psychiatry 2006; 189:182–183

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: E32 - E34
PubMed: 21677219

History

Published online: 1 April 2011
Published in print: Spring 2011

Authors

Details

Amitava Ganguli, M.D.
Department of Clinical Pharmacology and Therapeutics Royal Liverpool University HospitalSchool of Biomedical Sciences Department of Pharmacology & Therapeutics University of Liverpool Liverpool, UK
R. Fitzgerald, M.D.
Department of Clinical Pharmacology and Therapeutics Royal Liverpool University HospitalSchool of Biomedical Sciences Department of Pharmacology & Therapeutics University of Liverpool Liverpool, UK
L. Walker, M.D.
Department of Clinical Pharmacology and Therapeutics Royal Liverpool University HospitalSchool of Biomedical Sciences Department of Pharmacology & Therapeutics University of Liverpool Liverpool, UK
M. Beadsworth, M.D.
Department of Clinical Pharmacology and Therapeutics Royal Liverpool University HospitalSchool of Biomedical Sciences Department of Pharmacology & Therapeutics University of Liverpool Liverpool, UK
H.C. Mwandumba, M.D.
Department of Clinical Pharmacology and Therapeutics Royal Liverpool University HospitalSchool of Biomedical Sciences Department of Pharmacology & Therapeutics University of Liverpool Liverpool, UK

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share